Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HD73
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 93 | 97 | PF00656 | 0.451 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.636 |
CLV_NRD_NRD_1 | 61 | 63 | PF00675 | 0.515 |
CLV_PCSK_KEX2_1 | 256 | 258 | PF00082 | 0.750 |
CLV_PCSK_KEX2_1 | 278 | 280 | PF00082 | 0.735 |
CLV_PCSK_KEX2_1 | 60 | 62 | PF00082 | 0.742 |
CLV_PCSK_KEX2_1 | 82 | 84 | PF00082 | 0.503 |
CLV_PCSK_PC1ET2_1 | 256 | 258 | PF00082 | 0.750 |
CLV_PCSK_PC1ET2_1 | 278 | 280 | PF00082 | 0.735 |
CLV_PCSK_PC1ET2_1 | 60 | 62 | PF00082 | 0.742 |
CLV_PCSK_PC1ET2_1 | 82 | 84 | PF00082 | 0.503 |
CLV_PCSK_SKI1_1 | 128 | 132 | PF00082 | 0.643 |
CLV_PCSK_SKI1_1 | 169 | 173 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 38 | 42 | PF00082 | 0.589 |
CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.525 |
DOC_MAPK_gen_1 | 34 | 42 | PF00069 | 0.652 |
DOC_PP2B_LxvP_1 | 204 | 207 | PF13499 | 0.405 |
DOC_PP4_FxxP_1 | 245 | 248 | PF00568 | 0.610 |
DOC_USP7_MATH_1 | 240 | 244 | PF00917 | 0.664 |
DOC_USP7_MATH_1 | 66 | 70 | PF00917 | 0.658 |
DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.486 |
DOC_USP7_UBL2_3 | 14 | 18 | PF12436 | 0.640 |
LIG_14-3-3_CanoR_1 | 116 | 121 | PF00244 | 0.589 |
LIG_14-3-3_CanoR_1 | 239 | 249 | PF00244 | 0.744 |
LIG_14-3-3_CanoR_1 | 257 | 262 | PF00244 | 0.483 |
LIG_14-3-3_CanoR_1 | 37 | 43 | PF00244 | 0.539 |
LIG_14-3-3_CanoR_1 | 92 | 99 | PF00244 | 0.674 |
LIG_AP2alpha_2 | 120 | 122 | PF02296 | 0.663 |
LIG_BIR_III_2 | 96 | 100 | PF00653 | 0.454 |
LIG_BRCT_BRCA1_1 | 107 | 111 | PF00533 | 0.614 |
LIG_BRCT_BRCA1_1 | 118 | 122 | PF00533 | 0.587 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.447 |
LIG_FHA_2 | 115 | 121 | PF00498 | 0.529 |
LIG_FHA_2 | 179 | 185 | PF00498 | 0.547 |
LIG_FHA_2 | 39 | 45 | PF00498 | 0.634 |
LIG_FHA_2 | 68 | 74 | PF00498 | 0.627 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.453 |
LIG_FHA_2 | 91 | 97 | PF00498 | 0.575 |
LIG_Integrin_isoDGR_2 | 198 | 200 | PF01839 | 0.419 |
LIG_LIR_Apic_2 | 117 | 121 | PF02991 | 0.709 |
LIG_LIR_Apic_2 | 243 | 248 | PF02991 | 0.607 |
LIG_LIR_Apic_2 | 30 | 36 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 170 | 175 | PF02991 | 0.485 |
LIG_Pex14_1 | 118 | 122 | PF04695 | 0.704 |
LIG_SH2_SRC | 142 | 145 | PF00017 | 0.465 |
LIG_SH2_SRC | 267 | 270 | PF00017 | 0.574 |
LIG_SH2_STAP1 | 142 | 146 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 103 | 106 | PF00017 | 0.595 |
LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.547 |
LIG_SH3_3 | 37 | 43 | PF00018 | 0.614 |
LIG_SH3_3 | 48 | 54 | PF00018 | 0.678 |
LIG_TRAF2_1 | 3 | 6 | PF00917 | 0.499 |
MOD_CK1_1 | 49 | 55 | PF00069 | 0.713 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.383 |
MOD_CK2_1 | 146 | 152 | PF00069 | 0.577 |
MOD_CK2_1 | 178 | 184 | PF00069 | 0.572 |
MOD_CK2_1 | 67 | 73 | PF00069 | 0.465 |
MOD_CK2_1 | 78 | 84 | PF00069 | 0.399 |
MOD_GlcNHglycan | 112 | 115 | PF01048 | 0.718 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.622 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.661 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.713 |
MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.680 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.718 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.670 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.543 |
MOD_GSK3_1 | 214 | 221 | PF00069 | 0.650 |
MOD_GSK3_1 | 248 | 255 | PF00069 | 0.638 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.617 |
MOD_GSK3_1 | 281 | 288 | PF00069 | 0.699 |
MOD_GSK3_1 | 72 | 79 | PF00069 | 0.561 |
MOD_GSK3_1 | 88 | 95 | PF00069 | 0.521 |
MOD_N-GLC_1 | 158 | 163 | PF02516 | 0.408 |
MOD_N-GLC_1 | 263 | 268 | PF02516 | 0.649 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.637 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.510 |
MOD_NEK2_1 | 76 | 81 | PF00069 | 0.628 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.581 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.499 |
MOD_PKA_1 | 256 | 262 | PF00069 | 0.738 |
MOD_PKA_2 | 256 | 262 | PF00069 | 0.738 |
MOD_PKA_2 | 76 | 82 | PF00069 | 0.657 |
MOD_Plk_1 | 158 | 164 | PF00069 | 0.634 |
MOD_Plk_1 | 55 | 61 | PF00069 | 0.669 |
MOD_Plk_1 | 72 | 78 | PF00069 | 0.479 |
MOD_Plk_4 | 281 | 287 | PF00069 | 0.741 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.573 |
TRG_DiLeu_BaEn_1 | 187 | 192 | PF01217 | 0.679 |
TRG_DiLeu_LyEn_5 | 187 | 192 | PF01217 | 0.411 |
TRG_NLS_MonoExtC_3 | 59 | 64 | PF00514 | 0.498 |
TRG_Pf-PMV_PEXEL_1 | 92 | 96 | PF00026 | 0.688 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PA94 | Leptomonas seymouri | 57% | 100% |
A0A1X0NIP3 | Trypanosomatidae | 43% | 100% |
A0A3S7WY29 | Leishmania donovani | 81% | 100% |
A0A422P481 | Trypanosoma rangeli | 44% | 100% |
D0A6Y5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9AH27 | Leishmania infantum | 81% | 100% |
E9AWK5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q4QAW5 | Leishmania major | 81% | 100% |
V5DSP6 | Trypanosoma cruzi | 43% | 100% |